Nice announcement but I'm not sold on validation as yet.
At the end of the day, this was a nonclinical study (i.e. self-validation not independent) and they determined success by identifying 1 person (outta 66 sampled) who differed from the self-report (the others knew their condition).
For now it's a positive for SH but, from an investment perspective, I'll hang on for the clinical trial results.
Not sure the market has/will differentiated on this ST (+32% today suggests so) and so it'll present a nice trade.
Nice announcement but I'm not sold on validation as yet. At the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.45M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.6¢ | $1.298K | 36.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 397655 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 1025929 | 3 |
View Market Depth
| Last trade - 10.44am 26/07/2024 (20 minute delay) ? |
| TRI (ASX) Chart |